Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
131.69
+8.52 (6.92%)
Apr 9, 2026, 12:35 PM EDT - Market open
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.88 billion as of April 9, 2026. Its market cap has increased by 502.73% in one year.
Market Cap
1.88B
Enterprise Value
1.72B
1-Year Change
502.73%
Ranking
Category
Stock Price
$131.69
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.88B, an increase of 1,209.28%. That is a compound annual growth rate of 612.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.76B | 42.30% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.82B |
| AnaptysBio | 1.79B |
| Ocular Therapeutix | 1.76B |
| Vericel | 1.74B |
| Innoviva | 1.70B |
| Sionna Therapeutics | 1.68B |
| Recursion Pharmaceuticals | 1.66B |
| Trevi Therapeutics | 1.64B |